Official recall notice

FDA DrugClass IIINotable

FDA Recall: Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intr

Recall date
2026-09-09
Category
Drug
FDA class
Class III

Why it was recalled

Hazard

Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

Product description

Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

Affected products

Lot#: 1221973, Exp 3/24/2027

Related Recalls